Menatetrenone and Rashes - a phase IV clinical study of FDA data

Summary:

Rashes is found among people who take Menatetrenone, especially for people who are female, 60+ old.

The phase IV clinical study analyzes which people take Menatetrenone and have Rashes. It is created by eHealthMe based on reports of 485 people who have side effects when taking Menatetrenone from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

485 people reported to have side effects when taking Menatetrenone.
Among them, 21 people (4.33%) have Rashes.

What is Menatetrenone?

Menatetrenone has active ingredients of vitamin k. eHealthMe is studying from 489 Menatetrenone users for its effectiveness, alternative drugs and more.

What is Rashes?

Rashes (redness) is found to be associated with 5,002 drugs and 5,962 conditions by eHealthMe.

Number of Menatetrenone and Rashes reports submitted per year:

* Approximation only. Some reports may have incomplete information.

Do you take Menatetrenone and have Rashes?

Check whether Rashes is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Rashes and when was it recovered:

Rashes in Menatetrenone

Expand to all the drugs that have ingredients of vitamin k:

Rashes and drugs with ingredients of vitamin k (195 reports)

Alternative drugs to, pros and cons of Menatetrenone:

Menatetrenone (489 reports)

Rashes treatments and more:

Rashes (603,811 reports)

COVID vaccines that are related to Rashes:

Common drugs associated with Rashes:

All the drugs that are associated with Rashes:

Rashes (5,002 drugs)

Common conditions associated with Rashes:

All the conditions that are associated with Rashes:

Rashes (5,962 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on vitamin k (the active ingredients of Menatetrenone) and Menatetrenone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.